Investigating the efficacy of concomitant aspirin and enoxaparin administration in patients undergoing cerebral aneurysm surgery

Investigating the efficacy of concomitant aspirin and enoxaparin administration in patients undergoing cerebral aneurysm surgery at Golestan Hospital in Ahvaz: A Clinical trial study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251213068305N1

Enrollment

Registered

2026-01-17

Start date

2026-02-20

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Aneurysm. Cerebral aneurysm, nonruptured

Interventions

Intervention 1: Enoxaparin 60 mg (ACTOVERCO, Iran) will be injected subcutaneously once a day. Treatment will begin 24 hours after surgery and will continue until the patient is discharged. The inject

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with intracranial cerebral aneurysm and aneurysm-induced aSAH Patients older than 20 years of age Patient consent to participate in the study

Exclusion criteria

Exclusion criteria: History of surgery Traumatic patients Use of neuroleptic drugs

Design outcomes

Primary

Measure	Time frame
Vasospasm. Timepoint: In hospitalization duration. Method of measurement: CT Scan, MRI.;Brain Infarctus. Timepoint: In hospitalization duration. Method of measurement: CT Scan, MRI.;Deep vein thrombosis. Timepoint: In hospitalization duration. Method of measurement: CT Scan.;Pulmonary thromboendarterectomy. Timepoint: In hospitalization duration. Method of measurement: CT Scan.;Brain Hemorrhage. Timepoint: In hospitalization duration. Method of measurement: CT Scan, MRI.	—

Measure

Time frame

Vasospasm. Timepoint: In hospitalization duration. Method of measurement: CT Scan, MRI.;Brain Infarctus. Timepoint: In hospitalization duration. Method of measurement: CT Scan, MRI.;Deep vein thrombosis. Timepoint: In hospitalization duration. Method of measurement: CT Scan.;Pulmonary thromboendarterectomy. Timepoint: In hospitalization duration. Method of measurement: CT Scan.;Brain Hemorrhage. Timepoint: In hospitalization duration. Method of measurement: CT Scan, MRI.

—

Secondary

Measure	Time frame
Patient's consciousness. Timepoint: In hospitalization duration. Method of measurement: Glasgow Coma Scale.;Survival. Timepoint: In hospitalization duration. Method of measurement: Mortality.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosein Safari

Ahvaz University of Medical Sciences

safari-h@ajums.ac.ir+98 61 3320 4516

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026